Feedback / Questions
fianlimab (REGN3767) - Regeneron
Keytruda (pembrolizumab) - Merck (MSD)
Libtayo (cemiplimab-rwlc) - Regeneron
http://clinicaltrials.gov/ct2/show/NCT06190951
May 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next